重磅新规落地！账户医疗险、分红健康险来了

Core Viewpoint - The article discusses the significant role of health insurance in China's national health security system by 2030, as outlined in the recent guidelines issued by the Financial Regulatory Bureau. It emphasizes the need for innovation and diversification in health insurance products to meet the growing demand for health protection among the population [3][5][6]. Group 1: Development Goals and Innovations - By 2030, health insurance is expected to play a more crucial role in the national health security system, with a multi-layered market structure that meets diverse needs across the population and lifecycle [5][6]. - The guidelines introduce innovative concepts such as account-based medical insurance and dividend health insurance, which expand the business forms and scope of commercial health insurance [6][7]. - The guidelines support the development of personal account-based long-term medical insurance, which is a model seen in countries with advanced health insurance systems [7][8]. Group 2: Regulatory Changes and Market Dynamics - The guidelines allow for an increase in the cost-sharing ratio of health management in health insurance products, which previously had a cap of 20%, enabling health insurance companies to enhance their service offerings [8][9]. - The guidelines encourage collaboration between health insurance companies and pharmaceutical/device firms to explore innovative payment methods for new drugs and technologies, thereby integrating health insurance with the medical and pharmaceutical sectors [9][10]. Group 3: Addressing High-Cost Treatments - The article highlights the role of commercial health insurance in providing coverage for high-cost treatments, such as CAR-T therapy, which is not yet included in the national health insurance directory [10][11]. - The guidelines aim to improve the multi-payment ecosystem, facilitating access to advanced medical technologies for patients [11][12]. Group 4: Future Directions - The Financial Regulatory Bureau plans to enhance the regulatory environment for health insurance, focusing on the development of floating yield health insurance and ensuring compliance with the new guidelines [11].